122 related articles for article (PubMed ID: 4820552)
21. Laboratory methods and quality control in the Toronto Tay-Sachs program.
Lowden JA; Skomorowski MA; Howard F
Prog Clin Biol Res; 1977; 18():221-6. PubMed ID: 601078
[No Abstract] [Full Text] [Related]
22. Carrier screening techniques for Tay-Sachs and other lysosomal storage diseases.
Kolodny EH
Prog Clin Biol Res; 1977; 18():213-9. PubMed ID: 601077
[No Abstract] [Full Text] [Related]
23. Tay-Sachs disease in South Africa.
Van Der Horst RL
S Afr Med J; 1973 Feb; 47(5):181-3. PubMed ID: 4684247
[No Abstract] [Full Text] [Related]
24. Testing for Tay-Sachs carriers.
Evans P
Br Med J; 1973 Aug; 3(5876):408. PubMed ID: 4730195
[No Abstract] [Full Text] [Related]
25. Tay-Sachs disease: from enzyme to prevention.
O'Brien JS
Fed Proc; 1973 Feb; 32(2):191-9. PubMed ID: 4734645
[No Abstract] [Full Text] [Related]
26. Tay-Sachs disease among Moroccan Jews.
Vecht J; Zeigler M; Segal M; Bach G
Isr J Med Sci; 1983 Jan; 19(1):67-9. PubMed ID: 6832951
[No Abstract] [Full Text] [Related]
27. Determination of Tay-Sachs genotypes in pregnant women.
Navon R; Mark Z; Mashiah S; Padeh B
Clin Genet; 1973; 4(3):286-7. PubMed ID: 4765212
[No Abstract] [Full Text] [Related]
28. Rapid test for the detection of Tay-Sachs disease heterozygotes and homozygotes by serum hexosaminidase assay.
Saifer A; Rosenthal AL
Clin Chim Acta; 1973 Feb; 43(3):417-21. PubMed ID: 4690912
[No Abstract] [Full Text] [Related]
29. Tay-Sachs carrier detection by mechanized serum hexosaminidase assay.
Rosenberg D; Cutler R
Clin Chim Acta; 1974 Jun; 53(2):247-53. PubMed ID: 4841990
[No Abstract] [Full Text] [Related]
30. Tay-Sachs disease: prospects for therapeutic intervention.
Desnick RJ; Goldberg JD
Prog Clin Biol Res; 1977; 18():129-41. PubMed ID: 601073
[No Abstract] [Full Text] [Related]
31. Tay-Sachs disease. Four Swedish cases with special regard to a genealogical investigation.
Eeg-Olofsson O; Akesson HO
Acta Neurol Scand; 1967; 43(S31):60. PubMed ID: 5583282
[No Abstract] [Full Text] [Related]
32. Automated determination of serum hexosaminidase A by pH inactivation for detection of Tay-Sachs disease heterozygotes.
Saifer A; Perle G
Clin Chem; 1974 May; 20(5):538-43. PubMed ID: 4826945
[No Abstract] [Full Text] [Related]
33. Kinetic determination of hexosaminidases for Tay-Sachs heterozygote screening.
Zinterhofer L; Schuttringer G
Clin Chem; 1976 Oct; 22(10):1631-4. PubMed ID: 975509
[TBL] [Abstract][Full Text] [Related]
34. Asialo GM-ganglioside in brain fetal Tay-Sachs disease.
Schneck L; Pinkett B; Volk BW
J Neurochem; 1975 Jan; 24(1):183-4. PubMed ID: 1110360
[No Abstract] [Full Text] [Related]
35. [Sandhoff's disease: clinical and genetic study of a French-Canadian child].
Melançon SB; Potier M; Geoffroy G; Dallaire L
Union Med Can; 1974 Jul; 103(7):1218-22. PubMed ID: 4210450
[No Abstract] [Full Text] [Related]
36. Caveats of antenatal diagnosis of Tay-Sachs disease.
Saifer A; Schneck L; Perle G; Valenti C; Volk BW
Am J Obstet Gynecol; 1973 Feb; 115(4):554-5. PubMed ID: 4685506
[No Abstract] [Full Text] [Related]
37. Tay-Sachs screening and prevention: the Canadian experience.
Lowden JA; Davidson J
Prog Clin Biol Res; 1977; 18():37-46. PubMed ID: 601088
[No Abstract] [Full Text] [Related]
38. Immunochemical studies on normal and Tay-Sachs' brain gangliosides.
Pascal TA; Saifer A; Gitlin J
Proc Soc Exp Biol Med; 1966 Mar; 121(3):739-43. PubMed ID: 4956833
[No Abstract] [Full Text] [Related]
39. Hexosaminidase-A and hexosaminidase-B: studies in Tay-Sachs' and Sandhoff's disease.
Srivastava SK; Beutler E
Nature; 1973 Feb; 241(5390):463. PubMed ID: 4122341
[No Abstract] [Full Text] [Related]
40. Membranous cytoplasmic bodies from Tay-Sachs disease. Gm-1-gangliosidosis (generalized gangliosidosis).
Suzuki K; Chen GC
J Neuropathol Exp Neurol; 1968 Jan; 27(1):142-3. PubMed ID: 5656560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
